Researchers from the Smidt Heart Institute at Cedars-Sinai have created an artificial intelligence tool to help identify hypertrophic cardiomyopathy and cardiac amyloidosis.
Their findings, outlined in a study published in JAMA Cardiology, could make it easier to detect and treat heart…
From: www.healthcareitnews.com – Read more